# Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS

> **NCT01801280** · PHASE4 · COMPLETED · sponsor: **Klemens Budde** · enrollment: 20 (actual)

## Conditions studied

- Transplantation
- Immunosuppression
- Drug Interaction

## Interventions

- **DRUG:** Mycophenolate sodium
- **DRUG:** Pantoprazole
- **DRUG:** Mycophenolate mofetil

## Key facts

- **NCT ID:** NCT01801280
- **Lead sponsor:** Klemens Budde
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-03
- **Final completion:** 2014-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01801280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01801280, "Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01801280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*